Comparison of hypoxia-inducible factor-1alpha expression before and after transcatheter arterial embolization in rabbit VX2 liver tumors

scientific article

Comparison of hypoxia-inducible factor-1alpha expression before and after transcatheter arterial embolization in rabbit VX2 liver tumors is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JVIR.2008.06.017
P932PMC publication ID2613192
P698PubMed publication ID18922400
P5875ResearchGate publication ID23384964

P50authorGayle WoloschakQ37828777
Riad SalemQ45736667
Reed A. OmaryQ86839285
P2093author name stringLaura M Kulik
Andrew C Larson
Robert J Lewandowski
Robert K Ryu
Guang-Yu Yang
Kent T Sato
Mary F Mulcahy
Sumeet Virmani
Thomas K Rhee
Barbara Szolc-Kowalska
P2860cites workA nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activationQ24294741
Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathwayQ24672316
Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastasesQ28139317
The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated MacrophagesQ28143066
Induction of HIF-1alpha in response to hypoxia is instantaneousQ28188144
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalQ29616865
Hypoxia-induced angiogenesis in human hepatocellular carcinomaQ35000262
Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survivalQ35011429
Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectivesQ35701281
Updated treatment approach to hepatocellular carcinoma.Q36097844
Resection and liver transplantation for hepatocellular carcinoma.Q36140302
Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinomaQ36845140
A comparison of chemoembolization endpoints using angiographic versus transcatheter intraarterial perfusion/MR imaging monitoring.Q39815833
Comparison of transcatheter intraarterial perfusion MR imaging and fluorescent microsphere perfusion measurements during transcatheter arterial embolization of rabbit liver tumors.Q39815846
Effect of transcatheter arterial embolization on levels of hypoxia-inducible factor-1alpha in rabbit VX2 liver tumors.Q40134286
Comparison of two different methods for inoculating VX2 tumors in rabbit livers and hind limbs.Q41317851
Angiogenesis in rabbit hepatic tumor after transcatheter arterial embolizationQ41947562
Partition of calibrated tris-acryl gelatin microspheres in the arterial vasculature of embolized nasopharyngeal angiofibromas and paragangliomas.Q51514323
Rapid progression of hepatocellular carcinoma after transcatheter arterial chemoembolization and percutaneous radiofrequency ablation in the primary tumour regionQ73729667
Hypoxia-inducible factor-1alpha expression in experimental cirrhosis: correlation with vascular endothelial growth factor expression and angiogenesisQ80575762
P433issue10
P304page(s)1483-1489
P577publication date2008-10-01
P1433published inJournal of Vascular and Interventional RadiologyQ15766548
P1476titleComparison of hypoxia-inducible factor-1alpha expression before and after transcatheter arterial embolization in rabbit VX2 liver tumors
P478volume19

Reverse relations

cites work (P2860)
Q37867126Advances in regional chemotherapy of the liver
Q38371669An overview of loco-regional treatments in patients and mouse models for hepatocellular carcinoma.
Q37366556Animal models of cancer in interventional radiology
Q39001861Arsenic trioxide: marked suppression of tumor metastasis potential by inhibiting the transcription factor Twist in vivo and in vitro
Q86651932Bone targeted bipolar cooled radiofrequency ablation in a VX-2 rabbit femoral carcinoma model
Q35230282Can we develop effective combination antiangiogenic therapy for patients with hepatocellular carcinoma?
Q38155505Chemoembolization in patients with hepatocellular carcinoma
Q87117255Chemoembolization of hepatocellular carcinoma
Q47573274Comparison of transcatheter arterial chemoembolization and microsphere embolization for treatment of unresectable hepatocellular carcinoma: a meta-analysis
Q35534035Comparison of two different laparotomy methods for modeling rabbit VX2 hepatocarcinoma
Q36224869Considerations for two inoculation methods of rabbit hepatic tumors: Pathology and image features
Q40575060Correlation of volumetric perfusion CT parameters with hypoxia inducible factor-1 alpha expression in a rabbit VX2 tumor model
Q90708115Establishment of Rabbit Liver VX2 Tumor Model Using Percutaneous Puncture Inoculation of Tumor Fragment Guided and Evaluated by Ultrasonography
Q43206549Expression of hypoxia-inducible factor-1alpha in liver tumors after transcatheter arterial embolization in an animal model
Q34962750Hepatic parenchymal changes following transcatheter embolization and chemoembolization in a rabbit tumor model
Q92669979Hyperactivation of IL-6/STAT3 pathway leaded to the poor prognosis of post-TACE HCCs by HIF-1α/SNAI1 axis-induced epithelial to mesenchymal transition
Q30491780Hypoxia as a target for drug combination therapy of liver cancer.
Q33576048Image-guided local delivery strategies enhance therapeutic nanoparticle uptake in solid tumors
Q38984450In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization?
Q41446079Liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in VX2 rabbit liver tumors
Q37619480Localized hyperthermia with iron oxide-doped yttrium microparticles: steps toward image-guided thermoradiotherapy in liver cancer.
Q37766546Loco-regional treatment of hepatocellular carcinoma
Q38152999Multispectral imaging: a review of its technical aspects and applications in anatomic pathology
Q34681150Perfusion reduction at transcatheter intraarterial perfusion MR imaging: a promising intraprocedural biomarker to predict transplant-free survival during chemoembolization of hepatocellular carcinoma
Q37017008Potentiality and boundaries of use of sorafenib in patients with hepatocellular carcinoma: awaiting the results of ongoing clinical trials.
Q46013875Preclinical Benefit of Hypoxia-Activated Intra-arterial Therapy with Evofosfamide in Liver Cancer.
Q33911988Quantitative 4D transcatheter intraarterial perfusion MRI for monitoring chemoembolization of hepatocellular carcinoma
Q39381670RNA interference of hypoxia-inducible factor-1 alpha improves the effects of transcatheter arterial embolization in rat liver tumors
Q35085486Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma
Q41785826Relevance of Rabbit VX2 Tumor Model for Studies on Human Hepatocellular Carcinoma: A MicroRNA-Based Study
Q54180674Superselective transarterial chemoembolization for hepatocellular carcinoma: recent progression and perspective.
Q26764896The Changes of HIF-1α and VEGF Expression After TACE in Patients With Hepatocellular Carcinoma
Q37103489Transarterial chemoembolization combined with sorafenib for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus
Q37704703Transarterial sorafenib chemoembolization: preliminary study of technical feasibility in a rabbit model
Q44697301Transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: recent progression and perspective
Q36347609Ultrasound-guided RNA interference targeting HIF-1 alpha improves the effects of transarterial chemoembolization in rat liver tumors
Q44325987Unconventional extrahepatic neovascularization after transplant hepatic artery thrombosis: a case report.
Q30248206Unresectable Hepatocellular Carcinoma: Radioembolization Versus Chemoembolization: A Systematic Review and Meta-analysis.

Search more.